Virtual Screening and Hit Identification
Hierarchical virtual screening for the discovery of new molecular scaffolds in antibacterial hit identification
12
Integrated Computational Approach for Virtual Hit Identification against Ebola Viral Proteins VP35 and VP40
31
Hit identification of IKKβ natural product inhibitor
8
Identification of novel molecular scaffolds for the design of MMP-13 inhibitors through Virtual Screening Methods
58
Identification of polyketide synthase 13 inhibitor: Pharmacophore-based virtual screening and molecular dynamics simulation
6
Identification of novel serotonin transporter compounds by virtual screening.
12
Identification of Bichalcones as Sirtuin Inhibitors by Virtual Screening and in Vitro Testing
11
Identification and validation of a potent dual Inhibitor of the P. falciparum M1 and M17 aminopeptidases using virtual screening
16
Identification of new inhibitors of Mdm2–p53 interaction via pharmacophore and structure-based virtual screening
12
Structure-based virtual screening and molecular docking for the identification of potential multi-targeted inhibitors against breast cancer
13
Identification of Bichalcones as Sirtuin Inhibitors by Virtual Screening and in Vitro Testing
6
We use Reaxys intensively for hit identification, hit-to-lead and lead optimization.
8
Identification of Small Molecule Memapsin Inhibitors via Computation based Virtual Screening
11
Contact-based ligand-clustering approach for the identification of active compounds in virtual screening
19
Identification of novel PTPRQ phosphatase inhibitors based on the virtual screening with docking simulations
10
IDENTIFICATION OF NOVEL PPARγ MODULATORS / PARTIAL AGONISTS THROUGH VIRTUAL SCREENING WORKFLOW
6
A NEW TARGET FOR DIABETES: HOMOLOGY MODELING AND IDENTIFICATION OF POTENTIAL LEADS THROUGH VIRTUAL SCREENING
7
Lead identification for the K-Ras protein: virtual screening and combinatorial fragment-based approaches
10
Computer-aided identification of lung cancer inhibitors through homology modeling and virtual screening
14
A method to enhance the hit ratio by a combination of structure-based drug screening and ligand-based screening
10